Article Information
History
- April 3, 2020.
Article Versions
- You are currently viewing Version 1 of this article (April 3, 2020 - 10:06).
- Version 2 (April 15, 2020 - 08:30).
- Version 3 (May 22, 2020 - 12:18).
- View Version 4, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Giuseppe Gritti, MD PhD1,
- Federico Raimondi, MD2,
- Diego Ripamonti, MD3,
- Ivano Riva, MD4,
- Francesco Landi, MD1,
- Leonardo Alborghetti3,
- Marco Frigeni, MD1,
- Marianna Damiani, MD4,
- Caterina Micò, MD1,
- Stefano Fagiuoli, MD5,
- Roberto Cosentini, MD6,
- Ferdinando Luca Lorini, MD4,
- Fabrizio Fabretti, MD4,
- Jonathan Morgan, MD7,
- Benjamin M.J. Owens, PhD7,
- Karan Kanhai, MD PhD7,
- Jim Cowburn, PhD7,
- Marco Rizzi, MD3,
- Fabiano Di Marco, MD2,8 and
- Alessandro Rambaldi, MD1,9,*
- 1Hematology, Azienda Socio Sanitario Territoriale Papa Giovanni XXIII Hospital, Bergamo, Italy
- 2Pneumology, Azienda Socio Sanitario Territoriale Papa Giovanni XXIII Hospital, Bergamo, Italy
- 3Infectious Disease, Azienda Socio Sanitario Territoriale Papa Giovanni XXIII Hospital, Bergamo, Italy
- 4Intensive Care, Azienda Socio Sanitario Territoriale Papa Giovanni XXIII Hospital, Bergamo, Italy
- 5Gastroenterology, Azienda Socio Sanitario Territoriale Papa Giovanni XXIII Hospital, Bergamo, Italy
- 6Emergency Units, Azienda Socio Sanitario Territoriale Papa Giovanni XXIII Hospital, Bergamo, Italy
- 7EUSA Pharma, Breakspear Park, Hemel Hempstead, UK
- 8Departments of Health Sciences, University of Milan, Milan, Italy
- 9Departments of Oncology-Hematology, University of Milan, Milan, Italy
- ↵*Corresponding author details:
Alessandro Rambaldi, arambaldi{at}asst-pg23.it +39-035-2673684
Posted April 03, 2020.
Use of siltuximab in patients with COVID-19 pneumonia requiring ventilatory support
